We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Arterial Transposition Correction Reduces Pregnancy Risk

By HospiMedica International staff writers
Posted on 14 Jan 2021
Women who had an arterial switch procedure to correct transposition of the great arteries (TGA) tolerated pregnancy well with few complications, according to a new study. More...


Researchers at Erasmus University Medical Center (Rotterdam, The Netherlands), the German Centre for Cardiovascular Research (DZHK; Berlin, Germany), and other institutions conducted a study involving 41 pregnant women (mean age 26.7 years) who underwent a prior arterial switch procedure for TGA. The primary end point was a major adverse cardiovascular event (MACE), defined as maternal death, supraventricular or ventricular arrhythmias, heart failure, aortic dissection, endocarditis, ischemic coronary events, and thromboembolic events.

The results showed that none of the women died during pregnancy or up to six months after delivery, and only two women (4.9%) suffered a MACE event, with one woman experiencing heart failure and the other developing ventricular tachycardia during the second and third trimesters, which was effectively treated with metoprolol. No deterioration in left or right ventricular function during pregnancy was evidenced. The median gestational age at delivery was 39 weeks and mean birth weight was 2,962 grams. Only one women suffered fetal loss. The study was published on December 22, 2020, in Journal of the American Heart Association.

“During the past 30 years, the arterial switch procedure has replaced the atrial switch procedure to correct TGA. Many cardiologists are reluctant to give green light for pregnancy in these cardiac patients, but our study proves that pregnancy is relatively safe,” said senior author Julien Roos-Hesselink, MD, of Erasmus University Medical Center. “In my opinion, it is also very important to let women lead a normal life, including pregnancy and starting a family.”

TGA arteries is a cyanotic congenital heart defect (CHD) in which the aorta and the pulmonary artery are reversed (transposed), with the aorta arising from the right ventricle and the pulmonary artery from the left. This switch causes deoxygenated blood from the right heart to be pumped immediately through the aorta and circulated throughout the body and the heart itself, bypassing the lungs altogether. At the same time, the left heart continuously pumps oxygenated blood back to the lungs via the pulmonary artery, instead of out into the body's circulation as it normally would.

Related Links:
Erasmus University Medical Center
German Centre for Cardiovascular Research



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.